Description: Molecure is an innovative biotechnological company dedicated to discovering and developing new drugs for the treatment of various incurable diseases.
To become a leading biotechnology company, globally recognized for discovering and developing breakthrough small molecule drugs acting on unexplored protein targets and novel RNA
Molecure’s exceptional in-house medicinal chemistry, biology and discovery capabilities allied to novel target biology gained from leading universities worldwide has enabled us to create a broad pipeline of drug candidates targeting unique and unexplored protein targets, as well as a cutting-edge small molecule mRNA targeting discovery platform.
On the 28th March 2022, OncoArendi changed its name to Molecure